Product Information
NUPLAZID 34 MG CAPSULE is a brand product labeled by Acadia Pharmaceuticals Inc., priced at $170.4960 per EA under NDC 63090034030. Its NADAC has been published 28 times since Dec 17, 2025.
Strength
34 mg/1
Manufacturer
Acadia Pharmaceuticals Inc.NDC
63090034030
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
3/18/2026
Active Ingredients
PIMAVANSERIN TARTRATEApproval Type
New Drug (NDA)
FDA Application
NDA210793On Market Since
6/28/2018
Pharmacological Classes
Price Statistics
The NADAC for NUPLAZID 34 MG CAPSULE has been published 28 times since Dec 17, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $170.4960 per EA |
|---|---|
| All-time high | $170.4960 (Jun 24, 2026) |
| All-time low | $170.4960 (Dec 17, 2025) |
| 52-week high | $170.4960 |
| 52-week low | $170.4960 |
| Median price | $170.4960 |
| Average price | $170.4960 |
| Largest weekly change | 0.0% (Dec 24, 2025) |
| Weeks tracked | 28 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the pimavanserin tartrate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of NUPLAZID 34 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for NUPLAZID 34 MG CAPSULE, manufactured by Acadia Pharmaceuticals Inc., is $170.4960 per EA (NDC 63090034030), effective Jun 24, 2026.
How has the price of NUPLAZID 34 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for NUPLAZID 34 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for NUPLAZID 34 MG CAPSULE?
Since Dec 17, 2025, the NADAC for NUPLAZID 34 MG CAPSULE has ranged from a low of $170.4960 (Dec 17, 2025) to a high of $170.4960 (Jun 24, 2026), with a median of $170.4960 per EA.
Are there cheaper alternatives to NUPLAZID 34 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of NUPLAZID 34 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures NUPLAZID 34 MG CAPSULE?
NUPLAZID 34 MG CAPSULE (NDC 63090034030) is labeled by Acadia Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification